{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. The \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. It involves redesignating paragraphs, updating fee amounts, and publishing fees in the Federal Register. The \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. It involves updating fee amounts and publishing fees in the Federal Register for fiscal years 2006 and 2007. The Secretary may use unobligated carryover balances from previous fiscal years to ensure sufficient fee revenues are available. The Secretary can use unobligated carryover balances from previous fiscal years for fee revenues in fiscal years 2006 and 2007, ensuring a minimum reserve for fiscal year 2008. Notice must be given to Congress before using these funds. The Secretary can use unobligated carryover balances from previous fiscal years for fee revenues in fiscal years 2006 and 2007, ensuring a minimum reserve for fiscal year 2008. Notice must be given to Congress before using these funds, with specific committees to be notified. The definition of 'small business' for this purpose is an entity reporting $30,000,000 or more. The House of Representatives amended subsection (d) to define 'small business' as an entity reporting $30,000,000 or less in gross receipts or sales in its most recent tax return. The House of Representatives amended subsection (d) to define 'small business' as an entity reporting $100,000,000 or less in gross receipts or sales in its most recent tax return. For fiscal year 2005, the Secretary must meet performance goals if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor. For fiscal year 2005, the appropriated amount must meet performance goals if it is equal to or greater than $205,720,000 multiplied by the adjustment factor. If the appropriated amount is more than 1 percent less than the specified amount, certain conditions apply. For fiscal year 2005, the appropriated amount must meet performance goals if it is equal to or greater than $205,720,000 multiplied by the adjustment factor. Certain conditions apply if the appropriated amount is more than 1 percent less than the specified amount. Amendments include striking \"2003 through\" and inserting \"2005 and\", as well as inserting \"more than 1 percent\" after \"years, is\". In subsection (h)(3), amendments are made to subparagraphs (C), (D), and (E) for fiscal years 2006 and 2007. Additionally, \"subsection (c)(5)\" is replaced with \"subsection (c)(1)\" throughout the text. Amendments are made for fiscal years 2006 and 2007, including replacing \"subsection (c)(5)\" with \"subsection (c)(1)\". Annual reports under the Medical Device User Fee and Modernization Act of 2002 will now include additional information for those fiscal years. For fiscal years 2006 and 2007, the annual reports under the Medical Device User Fee and Modernization Act of 2002 will include additional information on the number of applications and fees paid by businesses in different revenue categories. The Secretary will also certify the amounts appropriated for FDA salaries and expenses for those fiscal years. The Secretary will certify the amounts appropriated for FDA salaries and expenses for fiscal years 2006 and 2007. Businesses are categorized in $10,000,000 intervals. In section 737 of the Federal Food, Drug, and Cosmetic Act, the amounts for FDA salaries and expenses for fiscal year 2002 are adjusted by a factor. Section 502(u) is amended regarding reprocessed single-use devices requiring manufacturer labeling. Reprocessed single-use devices must bear the manufacturer's name, abbreviation, or symbol prominently. If the original device lacks manufacturer labeling, the reprocessed device can fulfill this requirement. The reprocessed single-use devices must prominently display the manufacturer's name, abbreviation, or symbol. If the original device does not have manufacturer labeling, a detachable label on the packaging can be used to meet this requirement. Guidance will be issued by the Secretary of Health and Human Services within 180 days to identify specific circumstances for compliance. The Secretary of Health and Human Services will issue guidance within 180 days to specify when the manufacturer's name, abbreviation, or symbol on reprocessed single-use devices is not considered prominent and conspicuous. The effective date for section 502(u) of the Federal Food, Drug, and Cosmetic Act is amended by the Medical Device User Fee Stabilization Act of 2005. The effective date for section 502(u) of the Federal Food, Drug, and Cosmetic Act is amended by the Medical Device User Fee Stabilization Act of 2005 to be 12 months after enactment or when the device is labeled with manufacturer information. The effective date for section 502(u) of the Federal Food, Drug, and Cosmetic Act is amended by the Medical Device User Fee Stabilization Act of 2005 to be 12 months after enactment or when the device is labeled with manufacturer information. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}